ralzate commited on
Commit
1d9080a
·
verified ·
1 Parent(s): 7d3bcc4

Tarjeta del modelo en español (reemplaza plantilla por defecto)

Browse files
Files changed (1) hide show
  1. README.md +136 -168
README.md CHANGED
@@ -1,199 +1,167 @@
1
  ---
 
 
2
  library_name: transformers
3
- tags: []
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
  ---
5
 
6
- # Model Card for Model ID
7
 
8
- <!-- Provide a quick summary of what the model is/does. -->
 
 
 
9
 
 
10
 
 
11
 
12
- ## Model Details
 
13
 
14
- ### Model Description
 
 
 
 
 
 
 
 
 
 
 
15
 
16
- <!-- Provide a longer summary of what this model is. -->
 
17
 
18
- This is the model card of a 🤗 transformers model that has been pushed on the Hub. This model card has been automatically generated.
19
 
20
- - **Developed by:** [More Information Needed]
21
- - **Funded by [optional]:** [More Information Needed]
22
- - **Shared by [optional]:** [More Information Needed]
23
- - **Model type:** [More Information Needed]
24
- - **Language(s) (NLP):** [More Information Needed]
25
- - **License:** [More Information Needed]
26
- - **Finetuned from model [optional]:** [More Information Needed]
27
 
28
- ### Model Sources [optional]
 
29
 
30
- <!-- Provide the basic links for the model. -->
 
31
 
32
- - **Repository:** [More Information Needed]
33
- - **Paper [optional]:** [More Information Needed]
34
- - **Demo [optional]:** [More Information Needed]
35
 
36
- ## Uses
 
37
 
38
- <!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
39
 
40
- ### Direct Use
41
 
42
- <!-- This section is for the model use without fine-tuning or plugging into a larger ecosystem/app. -->
 
 
 
 
43
 
44
- [More Information Needed]
 
45
 
46
- ### Downstream Use [optional]
47
 
48
- <!-- This section is for the model use when fine-tuned for a task, or when plugged into a larger ecosystem/app -->
 
 
 
49
 
50
- [More Information Needed]
51
 
52
- ### Out-of-Scope Use
 
 
 
 
 
 
 
 
 
 
 
 
53
 
54
- <!-- This section addresses misuse, malicious use, and uses that the model will not work well for. -->
55
 
56
- [More Information Needed]
 
 
 
 
 
 
57
 
58
- ## Bias, Risks, and Limitations
59
 
60
- <!-- This section is meant to convey both technical and sociotechnical limitations. -->
 
 
 
 
 
 
 
 
 
61
 
62
- [More Information Needed]
 
 
 
 
 
 
 
63
 
64
- ### Recommendations
65
-
66
- <!-- This section is meant to convey recommendations with respect to the bias, risk, and technical limitations. -->
67
-
68
- Users (both direct and downstream) should be made aware of the risks, biases and limitations of the model. More information needed for further recommendations.
69
-
70
- ## How to Get Started with the Model
71
-
72
- Use the code below to get started with the model.
73
-
74
- [More Information Needed]
75
-
76
- ## Training Details
77
-
78
- ### Training Data
79
-
80
- <!-- This should link to a Dataset Card, perhaps with a short stub of information on what the training data is all about as well as documentation related to data pre-processing or additional filtering. -->
81
-
82
- [More Information Needed]
83
-
84
- ### Training Procedure
85
-
86
- <!-- This relates heavily to the Technical Specifications. Content here should link to that section when it is relevant to the training procedure. -->
87
-
88
- #### Preprocessing [optional]
89
-
90
- [More Information Needed]
91
-
92
-
93
- #### Training Hyperparameters
94
-
95
- - **Training regime:** [More Information Needed] <!--fp32, fp16 mixed precision, bf16 mixed precision, bf16 non-mixed precision, fp16 non-mixed precision, fp8 mixed precision -->
96
-
97
- #### Speeds, Sizes, Times [optional]
98
-
99
- <!-- This section provides information about throughput, start/end time, checkpoint size if relevant, etc. -->
100
-
101
- [More Information Needed]
102
-
103
- ## Evaluation
104
-
105
- <!-- This section describes the evaluation protocols and provides the results. -->
106
-
107
- ### Testing Data, Factors & Metrics
108
-
109
- #### Testing Data
110
-
111
- <!-- This should link to a Dataset Card if possible. -->
112
-
113
- [More Information Needed]
114
-
115
- #### Factors
116
-
117
- <!-- These are the things the evaluation is disaggregating by, e.g., subpopulations or domains. -->
118
-
119
- [More Information Needed]
120
-
121
- #### Metrics
122
-
123
- <!-- These are the evaluation metrics being used, ideally with a description of why. -->
124
-
125
- [More Information Needed]
126
-
127
- ### Results
128
-
129
- [More Information Needed]
130
-
131
- #### Summary
132
-
133
-
134
-
135
- ## Model Examination [optional]
136
-
137
- <!-- Relevant interpretability work for the model goes here -->
138
-
139
- [More Information Needed]
140
-
141
- ## Environmental Impact
142
-
143
- <!-- Total emissions (in grams of CO2eq) and additional considerations, such as electricity usage, go here. Edit the suggested text below accordingly -->
144
-
145
- Carbon emissions can be estimated using the [Machine Learning Impact calculator](https://mlco2.github.io/impact#compute) presented in [Lacoste et al. (2019)](https://arxiv.org/abs/1910.09700).
146
-
147
- - **Hardware Type:** [More Information Needed]
148
- - **Hours used:** [More Information Needed]
149
- - **Cloud Provider:** [More Information Needed]
150
- - **Compute Region:** [More Information Needed]
151
- - **Carbon Emitted:** [More Information Needed]
152
-
153
- ## Technical Specifications [optional]
154
-
155
- ### Model Architecture and Objective
156
-
157
- [More Information Needed]
158
-
159
- ### Compute Infrastructure
160
-
161
- [More Information Needed]
162
-
163
- #### Hardware
164
-
165
- [More Information Needed]
166
-
167
- #### Software
168
-
169
- [More Information Needed]
170
-
171
- ## Citation [optional]
172
-
173
- <!-- If there is a paper or blog post introducing the model, the APA and Bibtex information for that should go in this section. -->
174
-
175
- **BibTeX:**
176
-
177
- [More Information Needed]
178
-
179
- **APA:**
180
-
181
- [More Information Needed]
182
-
183
- ## Glossary [optional]
184
-
185
- <!-- If relevant, include terms and calculations in this section that can help readers understand the model or model card. -->
186
-
187
- [More Information Needed]
188
-
189
- ## More Information [optional]
190
-
191
- [More Information Needed]
192
-
193
- ## Model Card Authors [optional]
194
-
195
- [More Information Needed]
196
-
197
- ## Model Card Contact
198
 
199
- [More Information Needed]
 
 
 
1
  ---
2
+ language: es
3
+ license: cc-by-4.0
4
  library_name: transformers
5
+ pipeline_tag: token-classification
6
+ base_model: dccuchile/bert-base-spanish-wwm-cased
7
+ tags:
8
+ - token-classification
9
+ - ner
10
+ - named-entity-recognition
11
+ - spanish
12
+ - español
13
+ - biomedical
14
+ - clinical
15
+ - medical
16
+ - oncology
17
+ - prostate-cancer
18
+ - cancer-de-prostata
19
+ - beto
20
+ metrics:
21
+ - f1
22
+ - precision
23
+ - recall
24
+ widget:
25
+ - text: "Paciente masculino de 72 años con adenocarcinoma de próstata, Gleason 3+3 y PSA de 9.9 ng/dL. Se inicia tratamiento con radioterapia y bicalutamida 50 mg diarios."
26
+ example_title: "Caso clínico de próstata"
27
+ - text: "Varón de 68 años con cáncer de próstata estadio T2N0M0, PSA 12.4. Prostatectomía radical en marzo de 2023."
28
+ example_title: "Estadificación y cirugía"
29
+ model-index:
30
+ - name: beto-prostata-ner
31
+ results:
32
+ - task:
33
+ type: token-classification
34
+ name: Named Entity Recognition
35
+ metrics:
36
+ - type: f1
37
+ value: 0.9757
38
+ name: F1 (micro, seqeval)
39
+ - type: precision
40
+ value: 0.9732
41
+ name: Precision
42
+ - type: recall
43
+ value: 0.9781
44
+ name: Recall
45
  ---
46
 
47
+ # BETO fine-tuned para NER de cáncer de próstata (español)
48
 
49
+ Modelo de **Reconocimiento de Entidades Nombradas (NER)** que extrae información clínica
50
+ de textos en **español** sobre **cáncer de próstata**. Es un fine-tuning de
51
+ [**BETO**](https://huggingface.co/dccuchile/bert-base-spanish-wwm-cased) (BERT entrenado
52
+ desde cero en español) para clasificación de tokens en formato **BIO** con 21 etiquetas.
53
 
54
+ > **F1 en test: 0.976** (seqeval, micro) · Precision 0.973 · Recall 0.978 · Accuracy 0.995
55
 
56
+ ## 🎯 Para qué sirve
57
 
58
+ Detecta y clasifica, palabra por palabra, **10 tipos de entidades clínicas** en informes y
59
+ notas médicas de oncología prostática:
60
 
61
+ | Entidad | Qué captura | Ejemplo |
62
+ |---|---|---|
63
+ | `EDAD` | Edad del paciente | *72 años* |
64
+ | `CANCER` | Tipo/diagnóstico de cáncer | *adenocarcinoma de próstata* |
65
+ | `GLEASON` | Escala de Gleason | *Gleason 3+3* |
66
+ | `BIOMARCADOR` | Biomarcadores (PSA, etc.) | *PSA de 9.9 ng/dL* |
67
+ | `TNM` | Estadificación TNM | *T2N0M0* |
68
+ | `TRATAMIENTO` | Tratamientos | *radioterapia* |
69
+ | `MEDICAMENTO` | Fármacos | *bicalutamida* |
70
+ | `DOSIS` | Dosis | *50 mg diarios* |
71
+ | `CIRUGIA` | Procedimientos quirúrgicos | *prostatectomía radical* |
72
+ | `FECHA` | Fechas | *marzo de 2023* |
73
 
74
+ Cada entidad se etiqueta en esquema **BIO** (`B-` inicio, `I-` continuación, `O` fuera),
75
+ para 21 etiquetas en total.
76
 
77
+ ## 🚀 Uso rápido
78
 
79
+ ```python
80
+ from transformers import pipeline
 
 
 
 
 
81
 
82
+ ner = pipeline("token-classification", model="ralzate/beto-prostata-ner",
83
+ aggregation_strategy="simple")
84
 
85
+ texto = ("Paciente masculino de 72 años con adenocarcinoma de próstata, "
86
+ "Gleason 3+3 y PSA de 9.9 ng/dL. Se inicia radioterapia y bicalutamida 50 mg.")
87
 
88
+ for e in ner(texto):
89
+ print(f"{e['entity_group']:14s} {e['score']*100:5.1f}% {e['word']}")
90
+ ```
91
 
92
+ Salida esperada (entidades como `EDAD`, `CANCER`, `GLEASON`, `BIOMARCADOR`,
93
+ `TRATAMIENTO`, `MEDICAMENTO`, `DOSIS`).
94
 
95
+ ## 📊 Resultados (conjunto de test, seqeval)
96
 
97
+ Barrido de *batch size* con 6 épocas y *early stopping*:
98
 
99
+ | batch size | Precision | Recall | F1 |
100
+ |---|---|---|---|
101
+ | **8** (recomendado) | 0.9732 | 0.9781 | **0.9757** |
102
+ | 16 | 0.9627 | 0.9705 | 0.9666 |
103
+ | 32 | 0.9488 | 0.9603 | 0.9545 |
104
 
105
+ Este repositorio publica la **mejor configuración (batch size 8)**. El F1 baja levemente al
106
+ aumentar el lote porque, con 6 épocas, los lotes pequeños dan más pasos de optimización.
107
 
108
+ ### Comparación con XLM-RoBERTa
109
 
110
+ En el mismo dataset, **BETO supera a XLM-RoBERTa-base** (multilingüe) en todo el barrido
111
+ (F1 0.955–0.976 vs 0.850–0.936). En NER clínico en español, un encoder **nativo en español**
112
+ y compacto rinde mejor que un multilingüe más grande: la especialización lingüística pesa
113
+ más que el tamaño.
114
 
115
+ ## 🧠 Detalles de entrenamiento
116
 
117
+ | | |
118
+ |---|---|
119
+ | **Modelo base** | `dccuchile/bert-base-spanish-wwm-cased` (BETO, ~110M parámetros) |
120
+ | **Tarea** | Token Classification (NER), 21 etiquetas BIO |
121
+ | **Dominio** | Texto clínico de cáncer de próstata en español |
122
+ | **Épocas** | 6 (con *early stopping*, paciencia 2, métrica F1) |
123
+ | **Learning rate** | 2e-5 |
124
+ | **Batch size** | 8 (este checkpoint) |
125
+ | **Longitud máxima** | 128 subtokens |
126
+ | **Optimizador** | AdamW, weight decay 0.01, warmup 0.1 |
127
+ | **Métrica** | seqeval (precision/recall/F1 a nivel de entidad) |
128
+ | **Hardware** | Apple M1 Pro (MPS), entrenamiento local |
129
+ | **Alineación** | etiqueta en el primer subtoken de cada palabra; resto a `-100` |
130
 
131
+ ## ⚠️ Limitaciones
132
 
133
+ - Entrenado en un **dominio específico** (cáncer de próstata en español); fuera de ese
134
+ dominio el rendimiento puede caer.
135
+ - El conjunto de datos es de tamaño moderado; entidades poco frecuentes pueden tener menor
136
+ recall.
137
+ - No sustituye el criterio clínico profesional. Pensado como apoyo a la extracción de
138
+ información, no para decisiones médicas autónomas.
139
+ - Hereda los posibles sesgos de BETO y del corpus clínico de entrenamiento.
140
 
141
+ ## 🏷️ Etiquetas
142
 
143
+ ```
144
+ O
145
+ B-EDAD, I-EDAD, B-CANCER, I-CANCER, B-GLEASON, I-GLEASON,
146
+ B-BIOMARCADOR, I-BIOMARCADOR, B-TNM, I-TNM, B-TRATAMIENTO, I-TRATAMIENTO,
147
+ B-MEDICAMENTO, I-MEDICAMENTO, B-DOSIS, I-DOSIS, B-CIRUGIA, I-CIRUGIA, B-FECHA, I-FECHA
148
+ ```
149
+
150
+ ## 📚 Cita
151
+
152
+ Si usas este modelo, cita también a BETO:
153
 
154
+ ```bibtex
155
+ @inproceedings{canete2020beto,
156
+ title={Spanish Pre-Trained BERT Model and Evaluation Data},
157
+ author={Cañete, José and Chaperon, Gabriel and Fuentes, Rodrigo and Ho, Jou-Hui and Kang, Hojin and Pérez, Jorge},
158
+ booktitle={PML4DC at ICLR 2020},
159
+ year={2020}
160
+ }
161
+ ```
162
 
163
+ ---
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
164
 
165
+ *Modelo afinado y publicado como parte de un proyecto de PLN en español (clasificación y NER
166
+ con Transformers). Reproducible en hardware modesto (Apple Silicon) mediante fine-tuning
167
+ completo para BETO y LoRA para modelos grandes.*